Stryker continues to deliver strong organic growth, having posted organic growth rates of around 10% for a long period of time now. Learn more about SYK stock here.

What Happened? Shares of medical technology company Stryker (NYSE:SYK) fell 2.9% in the afternoon session after it reported ...

The medical products maker now expects sales to grow 9.8% to 10.2% in the full year.

Analysts have recently evaluated Stryker and provided 12-month price targets. The average target is $417.57, accompanied by a ...

Medical technology company Stryker (NYSE:SYK) in Q3 CY2025, with sales up 10.2% year on year to $6.06 billion. Its non-GAAP ...

Stryker on Thursday raised the lower end of its full-year profit forecast after beating estimates for third-quarter earnings, banking on strong demand for its medical and surgical devices.

Stryker (NYSE:SYK) shares dipped slightly today on third-quarter results that topped the consensus Wall Street forecast.

Stryker has agreed to acquire Vocera Communications for $2.97 billion, kicking off medtech M&A in the new year. Vocera specializes in communication and workflow platforms as well as software for ...

Discover Stryker's Q3 2025 earnings call insights—organic growth, margin expansion, new acquisitions, and an upbeat outlook.

The medical device maker posted revenue of $6.06 billion in the period, also beating Street forecasts. Eight analysts surveyed by Zacks expected $6.04 billion. Stryker expects full-year earnings in ...